Life Science Executive Awards
Monday 16 November 2026City Central at the HAC, London, UKM&A of the Year
This award recognises the teams and organisations who have executed a truly transformational and high value M&A (full purchase or asset acquisition) deal for both the company and the wider industry.
Congratulations to this year's finalist roster.
There will be 1st (Gold), 2nd (Silver), and 3rd (Bronze) place announcements in each category, with 1st place exclusively awarded the bespoke trophy.
Criteria & Judging
Qualifying criteria:
- The lead company must be a European Life Science company
- Open to private, public companies, pharma, commercial leaders or big tech
- Deal must be an M&A deal NOT a license, partnership or alliance
- Deal to have completed in the period between 1 September 2025 and 1 August 2026
Judges will be paying particular attention to:
- Uniqueness or novelty of deal strategy / terms and structure
- Level of value creation / size of deal
- Strength of partner / partnership and deal teams
- Potential game / industry changing implications within next 12-months
- Post-deal performance
